Search

Your search keyword '"Witte, T."' showing total 170 results

Search Constraints

Start Over You searched for: Author "Witte, T." Remove constraint Author: "Witte, T." Database Journals@OVID Remove constraint Database: Journals@OVID
170 results on '"Witte, T."'

Search Results

1. Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party

3. Erythropoiesis‐stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower‐risk myelodysplastic syndrome

4. Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT

18. Influence of the IL17A locus in giant cell arteritis susceptibility

22. ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS FEASIBLE AFTER SOLID ORGAN TRANSPLANTATION: FINAL ANALYSIS BY THE EARLY COMPLICATIONS SUBCOMMITTEE OF THE COMPLICATIONS AND QUALITY OF LIFE WORKING PARTY, EBMT: PH-P351

24. REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANT IN PATIENTS WITH MULTIPLE MYELOMA: A COMPARISON OF TANDEM AUTO-ALLOGRAFT TO EARLY REDUCED INTENSITY ALLOGRAFT AS UPFRONT TRANSPLANT: AN EBMT ANALYSIS ON BEHALF OF THE PLASMA CELL DISORDERS: PH-O144

25. IMPACT OF CYTOGENETIC USING THE IPSS REVISED CYTOGENETIC CLASSIFICATION ON OUTCOME AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FOR MDS OR AML EVOLVING FROM MDS: A RETROSPECTIVE MULTICENTER STUDY OF THE CHRONIC MALIGNANCIES WORKING PARTY OF THE EBMT: PH-O012

26. Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice: This article has been corrected since Online Publication and a corrigendum has also been published

27. Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation

28. Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis

30. The German national registry for primary immunodeficiencies (PID)

36. Prophylaxis and treatment of graft-versus-host disease: EBMT - ELN working group recommendations for a standardized practice: 296

39. Tandem autologous/reduced-intensity allogeneic stem cell transplantation versus autologous transplantation in multiple myeloma - update of the EBMT-NMAM2000 study at 96 months median follow-up: 197

42. Reduced-intensity conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation : a study by the European Group for Blood and Marrow Transplantation Chronic Malignancies Working Party: O156

43. Higher probability of survival in complete remission following tandem autologous/reduced-intensity allogeneic transplantation compared to autologous transplantation alone in the NMAM2000 multiple myeloma trial as estimated by multistate models: O158

50. The EBMT activity survey: 1990-2010

Catalog

Books, media, physical & digital resources